That's essential, since the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (jeff brown stock market prediction). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was an advancement almost nobody discovered. But it's going to have extensive implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment chances in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 predictions). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back perhaps significantly before going higher - jeff brown. I've been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. However that's not the big concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so lots of excellent personal companies on the edge of hitting the general public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This opportunity has been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area for complimentary.
Emma Walsh here, handling editor of the Journal. Regular Journal readers understand that tech isn't our usual beat (brownstone research). And when it concerns tech investing, we leave it to the specialists. Thankfully, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (jeff brown stock predictions). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing rapid growth and developing extraordinary chances for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown genome sequencing. But in spite of what numerous readers might believe, this is a trend that's simply getting going. Even though the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown top biotech stock 2021). Losing two months of manufacturing and sales truly affects how numerous 5G devices are sold in the calendar year. When you consider all of that, offering 250 million units is exceptional. More significantly, the hold-ups brought on by the pandemic produced a load of bottled-up need. And that need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - future report review. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I've explained its 3 different stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Phase Three, 5G services start to be used (jeff brown predictions 2021). That's when we begin to see applications operating on 5G networks. Think about things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: Many individuals don't really appreciate the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities going forward will be huge. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For several years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were actually just 3 business running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is successfully a greenfield chance.
There's room for lots of companies to exist in this area. second wave. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can properly forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is essential because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been an experimental procedure. And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug therapies produced using this technology. This was one of those developments that nearly nobody observed. But it's going to have profound implications for curing disease. And, obviously, there will be lots of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back possibly significantly prior to going greater. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever published was on bitcoin - jeff brown 2021 stock predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my suggestion. But at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown top stock pick 2021. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the information is up to date as of February 2021, however we might not individually verify this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent viewpoint on the market. He's constantly on the hunt for new opportunities, and he shares numerous of his best picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he effectively anticipated some of the greatest financial events of the past twenty years. Although he does not appear to launch his choices to the general public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it ideal whenever, however Jeff Brown's precise forecasts have earned him legions of devoted followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study offers numerous research study services with a wide variety of expertises - jeff brown genome sequencing.
The company is also connected with Bonner & Partners, another well-respected research study publisher - tech predictions. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the very best investment research study has not been readily available to private investors. It has been typically booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. social media. The objective of Brownstone Research study is to make that sort of proprietary research study offered to any financiers looking to get an edge in the markets. The goal is simple to provide unique and profitable investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout most of America. If you understand even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. jeff bezos. Whatever he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. united arab emirates. might be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two advanced technologies: expert system and electrical cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving vehicles ever. It's nothing except the automobile industry's Holy Grail. As you understand, electric automobiles and self-driving automobile stocks have been substantial this year, however the Wall Street device has actually approved hype without much concrete outcome. Despite a drastic increase in competition over the previous couple of years, Brown still thinks Musk has the very best chance of putting it all together.
tech could be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transportation. Essentially, this technology would allow you to lease your cars and truck as a self-governing, self-driving taxi when you're not using it. You merely leave the vehicle and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the profits. It sounds outrageous, but it might be closed than you believe.